Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Completed 37Recruiting 18Active not recruiting 6Not yet recruiting 4Enrolling by invitation 3Unknown 2Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 2Thoracic 1

Conditions

Lung Neoplasms 1Liver Neoplasms 1Fibrosis 1Colorectal Neoplasms 1Colonic Neoplasms 1

Interventions

Cisplatin 9Specimen Handling 7Educational Status 7Standard of Care 6Interviews as Topic 6Drug Therapy 6Carboplatin 6Blood Specimen Collection 6Radiotherapy 5Nivolumab 5Chemoradiotherapy 5Surveys and Questionnaires 4Surgical Procedures, Operative 4Paclitaxel 4Oxaliplatin 4Observation 4Lenalidomide 4Fluorouracil 4Fluorodeoxyglucose F18 4Dexamethasone 4pembrolizumab 3lenvatinib 3camrelizumab 3Practice Guidelines as Topic 3Patient Navigation 3Methods 3Magnetic Resonance Spectroscopy 3Magnetic Resonance Imaging 3Gemcitabine 3Exercise 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Enrolling by invitation × Patient Navigation × Clear all
NCT06324110 2026-05-18

Evaluating the Impact of Centralized Interventions on Lung Cancer Screening Adherence in Community Settings, ACCELL Trial

Fred Hutchinson Cancer Center

Phase NA Enrolling by invitation
6,772 enrolled
Thoracic

Lung Neoplasms

NCT06458998 2026-02-23

GTI

University of Pittsburgh

Phase NA Enrolling by invitation
30,300 enrolled
Gastrointestinal

Colonic Neoplasms, Fibrosis, Liver Neoplasms

NCT07230795 2025-11-17

AI-informed Colorectal Cancer (CRC) Screening Navigation vs. Standard of Care Among Screening-naive Penn Medicine Patients 45-49 Years Old to Increase CRC Screening Uptake

Abramson Cancer Center at Penn Medicine

Phase NA Enrolling by invitation
7,120 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡